Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension?

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 289, Issue 4 58-4, 2005, Pages

  Wilcox, Christopher S ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Nitric oxide synthase; Reactive oxygen species; Salt sensitivity; Superoxide anion; Thromboxane prostanoid receptors

Indexed keywords

ANGIOTENSIN; CYCLOOXYGENASE 2; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; GLYCOPROTEIN GP 91; NITRIC OXIDE; OXYGEN; PROSTANOID RECEPTOR; PROTEIN NOX 1; PROTEIN P22; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM ION; SUPEROXIDE DISMUTASE; THROMBOXANE RECEPTOR; UNCLASSIFIED DRUG;

ARTERIOLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CONFERENCE PAPER; FEEDBACK SYSTEM; GLOMERULUS; HYPERTENSION; KIDNEY CORTEX; KIDNEY TUBULE; NONHUMAN; OXIDATIVE STRESS; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SALT LOADING; SODIUM TRANSPORT; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; DISEASE SUSCEPTIBILITY; HUMANS; HYPERTENSION; KIDNEY; MODELS, BIOLOGICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; WATER-ELECTROLYTE IMBALANCE;

EID: 25844513144     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00250.2005     Document Type: Conference Paper

References (285)

1. Alvarez B, Demicheli V, Duràn R, Trujillo M, Cerveñansky C, Freeman BA, and Radi R. Inactivation of human Cu, Zn superoxide dismutase by peroxynitrite and formation of histidinyl radical. Free Radic Biol Med 37: 813-822, 2004.
2. Ambasta RK, Kumar P, Griendling KK, Schmidt HHW, Busse R, and Brandes RP. Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem 279: 45935-45941, 2004.
3. Ames RP, Borkowski AJ, Sicinski AM, and Laragh JH. Prolonged infusions of ANG II and norepinephrine and blood pressure, electrolyte balance, aldosterone and cortisol secretion in normal man and in cirrhosis with ascites. J Clin Invest 44: 1171-1186, 1965.
4. Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, and Wilcox CS. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int 67: 1890-1898, 2005.
5. Babior BM. NADPHoxidase: an update. Blood 93: 1464-1476, 1999.
6. Bachmann S and Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 24: 112-119, 1994.
7. Barri YM, Limacher MC, and Wilcox CS. Extreme blood pressure fluctuations in a patient with intact autonomic reflexes and intact sodium conservation. J Am Soc Nephrol 6: 347-353, 1995.
8. Barton CH, Ni Z, and Vazari ND. Blood pressure response to hypoxia: role of nitric oxide synthase. Am J Hypertens 16: 1043-1048, 2003.
9. Barton CH, Ni Z, and Vaziri ND. Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension. Kidney Int 60: 1083-1087, 2001.
10. Berry C, Brosnan MJ, Fennell J, Hamilton CA, and Dominiczak AF. Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens 10: 247-255, 2001.
11. Beswick RA, Dorrance AM, Leite R, and Webb C. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38: 1107-1111, 2001.
12. Bianchi P, Seguelas MH, Parini A, and Cambon C. Activation of proapoptotic cascade by dopamine in renal epithelial cells is fully dependent on hydrogen peroxide generation by monoamine oxidases. J Am Soc Nephrol 14: 855-862, 2003.
13. Bosse HM and Bachmann S. Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension. Hypertension 30: 948-952, 1997.
14. Bosse HM, Bohm R, Resch S, and Bachmann S. Parallel regulation of constitutive NO synthase and renin at JGA of rat kidney under various stimuli. Am J Physiol Renal Fluid Electrolyte Phvsiol 269: F793-F805, 1995.
15. Briggs JP and Schnermann J. Control of renin release and glomerular vascular tone by the juxtaglomerular apparatus. In: Hypertension: Pathophysiology, Diagnosis and Management, edited by Laragh JH and Brenner BM. New York: Raven Press, 1995, p. 1359-1384.
16. Brown AJ, Casals-Stenzel J, Gofford S, Lever AF, and Morton JJ. Comparison of fast and slow pressor effects of ANG II in the conscious rats. Am J Physiol Heart Circ Physiol 241: H381-H388, 1981.
17. Brown GC. Nitric oxide and mitochondrial respiration. Biochim Biophys Acta 1411: 351-369, 1999.
18. Brown R, Ollerstam A, and Persson AEG. Neuronal nitric oxide synthase inhibition sensitizes the tubuloglomerular feedback mechanisms after volume expansion. Kidney Int 65: 1349-1356, 2004.
19. Cai H, Griendling K, and Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24: 471-478, 2003.
20. Cai H, Zongming L, Dikalov S, Holland SM, Hwang J, Jo H, Dudley SC, and Harrison DG. NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to ANG II. J Biochem (Tokyo) 277: 48311-48317, 2002.
21. Calver A, Collier J, Leone A, Moncada S, and Vallance P. Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arteriolar bed of healthy volunteers. J. Hum Hypertens 1: 193-194, 1993.
22. Campbell WG, Gahnem F, Catanzaro DF, James GD, Camargo MJF, Laragh JH, and Sealey JE. Plasma and renal prorenin/renin, renin mRNA, and blood pressure in Dahl salt-sensitive and salt-resistant rats. Hypertension 27: 1121-1133, 1996.
23. Cantuti-Castelvetri I and Joseph JA. Differential effect of dopamine catabolism and uptake inhibition on dopamine-induced calcium dysregulation and viability loss. Free Radic Biol Med 27: 1393-1404, 1999.
24. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, and Wilcox CS. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase and SODs expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003.
25. Chabrashvili T, Tojo A, Onozato M, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, and Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39: 269-274, 2002.
26. Chen J, Rusnak M, Luedtke RR, and Sidhu A. D1 dopamine receptor mediates dopamine-induced cytotoxicity via the ERK signal cascade. J Biol Chem 279: 39317-39330, 2004.
27. Chen X, Touyz RM, Park JB, and Schriffrin EL. Antioxidant effects of vitamin C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 38: 606-611, 2001.
28. Chen Y, Chami A, Wilcox CS, and Welch WJ. Oxygen availability limits superoxide production by renal NADPH oxidase (Abstract). J Am Soc Nephrol 15, 14A, 2004.
29. 2-induced vasoconstriction of in vivo mouse cremaster and mesenteric arterioles (Abstract). FASEB J 19: A1231, 2005.
30. 2 counteracts the vasodilator natriuretic effects of superoxide dismutation by Tempol in renal medulla. Am J Physiol Regul Integr Comp Physiol 285: R827-R833, 2003.
31. Chu Y, Iida S, Lund DD, Weiss RM, DiBona GF, Watanabe Y, Faraci FM, and Heistad DD. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats. Role of heparin-binding domain. Circ Res 92: 461-468, 2003.
32. Cowley AW Jr and Roman RJ. The role of the kidney in hypertension. JAMA 275: 1581-1589, 1996.
33. Craven PA, Studer RK, and DeRubertis FR. Thromboxane/prostaglandin endoperoxide-induced hypertrophy of rat vascular smooth muscle cells is signaled by protein kinase C-dependent increases in transforming growth factor-β. Hypertension 28: 169-176, 1996.
34. de Cavanagh EM, Piotrkowski B, Basso N, Stella I, Inserra F, Ferder L, and Fraga CG. Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J 17: 1096-1098, 2003.
35. +-resorbtion. Arch Ges Physiol 273: 636-650, 1961.
36. Deng X, Welch WJ, and Wilcox CS. Role of nitric oxide in short-term and prolonged effects of ANG II on renal hemodynamics. Hypertension 27: 1173-1179, 1996.
37. Dickhout JG, Mori T, and Cowley Jr AW Tubulovascular nitric oxide crosstalk: buffering of ANG II-induced medullary vasoconstriction. Circ Res 91: 487-493, 2002.
38. Dickinson CJ and Yu R. Mechanisms involved in the progressive pressor response to very small amounts of ANG II in conscious rabbits. Circ Res 20: II-157-II-163, 1967.
39. Ding Y, Gonick HC, and Vaziri ND. Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells. Am J Hypenens 13: 552-555, 2000.
40. Ding Y, Gonick HC, Vaziri ND, Liang K, and Wei L. Lead-induced hypertension. III. Increased hydroxyl radical production. Am J Hypertens 14: 169-173, 2001.
41. phox is regulated by a redox-sensitive pathway in endothelial cells. Free Radic Biol Med 38: 616-630, 2005.
42. Eiserich JP, Baldus S, Brennen ML, Ma W, Zhang C, Tousson A, Castro L, Lusis AJ, Nauseef WM, White CR, and Freeman BA. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296: 2391-2394, 2002.
43. Elmarakby AA, Loomis ED, Pollock JS, and Pollock DM. NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 45: 283-287, 2005.
44. Everett PB and Senogles SE. D3 dopamine receptor activates phospholipase D through a pertussis toxin-insensitive pathway. Neurosci Lett 371: 34-39, 2004.
45. Fine LG, Bandyopadhay D, and Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int 57: S22-S26, 2000.
46. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, and Busse R. Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88: 44-51, 2001.
47. Franco M, Tapia E, Santamaria J, Zafra I, García-Torres R, Gordon KL, Pons H, and Herrera-Acosta J. Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after ANG II exposure. J Am Soc Nephrol 12: 2263-2271, 2001.
48. Francois H, Athirakul K, Mao L, Rockman H, and Coffman TM. Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 43: 364-369, 2004.
49. phox in vitro. J Biol Chem 271: 22578-22582, 1996.
50. Fukai T, Folz RJ, Landmesser U, and Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55: 239-249, 2002.
51. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, and Harrison DG. Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin invest 105: 1631-1639, 2000.
52. Fukai T, Siegfried MR, Ushio-Fukai M, Griendling KK, and Harrison DG. Modulation of extracellular superoxide dismutase expression by ANG II and hypertension. Circ Res 85: 23-28, 1999.
53. phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80: 45-51, 1997.
54. Garcia CE, Kilcoyne CM, Cardillo C, Cannon RO, III, Quyyumi AA, and Panza JA. Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. Hypertension 26: 863-868, 1995.
55. phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J Biol Chem 278: 20006-20012, 2003.
56. Phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32, 2000.
57. Gorzalczany Y, Alloul N, Sigal N, Weinbaum C, and Pick E. A prenylated p67phox-Rac1 chimera elicits NADPH-dependent superoxide production by phagocyte membranes in the absence of an activator and of p47phox: conversion of a pagan NADPH oxidase to monotheism. J Biol Chem 277: 18605-18610, 2002.
58. Griendling KK and FitzGerald Ga. Oxidative stress and cardiovascular injury: part II: animal and human studies. Circulation 108: 2034-2040, 2003.
59. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
60. Grima G, Benz B, Parpura V, Cuenod M, and Do KQ. Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia. Schizophr Res 62: 213-224, 2003.
61. Grisk O and DiBona GF. Cardiopulmonary baroreflex in NaCl-induced hypertension in borderline hypertensive rats. Hypertension 29: 464-470, 1997.
62. Groholm T, Finckenberg P, Palojoki E, Saraste A, Backlund T, Eriksson A, Laine M, Mervaala E, and Tikkanen I. Cardioprotective effects of vasopeptidase inhibition vs. angiotensin type 1-receptor blockade in spontaneously hypertensive rats on a high-salt diet. Hypertens Res 27: 609-618, 2004.
63. Gryglewski RJ, Palmer RMJ, and Moncada S. Superoxide anion is involved in breakdown of endothelium-derived vascular relaxing factor. Nature 320: 454-456, 1986.
64. Guyton AC, Hall JE, Coleman TG, Manning RD Jr, and Norman RA. The dominant role of the kidneys in long-term arterial pressure regulation in normal and hypertensive states. Hypertens 1311-1326, 2000.
65. 2 receptors: where have you gone? Prostaglandins Other Lipid Mediat 60: 175-189, 2000.
66. Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, and Dominiczak AF. NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 40: 755-762, 2002.
67. Hamilton CA, Brosnan MJ, McIntyre M, Graham D, and Dominiczak AF. Superoxide excess in hypertension and aging: a common cause of endothelial dysfunction. Hypertension 37: 529-534, 2001.
68. Harrison DG, Cai H, Landmesser U, and Griendling KK. Interactions of ANG II with NAD(P)H oxidase, oxidant stress, and cardiovascular disease. J. Renin Angiotensin Aldosterone Syst 4: 51-61, 2003.
69. Harrison R. Structure and function of xanthine oxidoreductase: where are we now? Free Radic Biol Med 33: 774-797, 2002.
70. 1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol Renal Physiol 273: F170-F177, 1997.
71. Hatoum OA, Binion DG, Miura H, Telford G, Otterson MF, and Gutterman DD. Role of hydrogen peroxide in Ach-induced dilation of human submucosal intestinal microvessels. Am J Physiol Heart Circ Physiol 288: H48-H54, 2005.
72. Haynes WG, Noon JP, Walker BR, and Webb DJ. L-NMMA increases blood pressure in man. Lancet 342: 931-932, 1993.
73. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683, 2004.
74. Hogg N, Darley-Usmar VM, Wilson MT, and Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J 281: 419-424, 1992.
75. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ramachandran R, Wersinger SR, Soares-da-Silva P, Liu Z, Grinberg A, Drago J, Young WS III, Westphal H, Jose PA, and Sibley DR. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci 22: 10801-10810, 2002.
76. Iglarz M, Touyz RM, Viel EC, Amiri F, and Schiffrin EL. Involvement of oxidative stress in the profibrotic action of aldosterone: interaction with the renin-angiotensin system. Am J Hypertens 17: 597-603, 2004.
77. Imig JD. Afferent arteriolar reactivity to angtiotensin II is enhanced during the early phase of ANG II hypertension. Am J Hypertens 13: 810-818, 2000.
78. 2 and modulation by lipoxygenase and P-450 pathways. Am J Physiol Renal Physiol F274-F282, 1997.
79. Imig JD, Kitiyakara C, and Wilcox CS. Arachidonate metabolites. In: The Kidney: Physiology and Pathophysiology (2nd ed.), edited by Seldin DW and Giebisch G. New York: Raven Press, 2000, p. 875-889.
80. Imig JD and Navar LG. Afferent arteriolar response to arachidonic acid: involvement of metabolic pathways. Am J Physiol Renal Fluid Electrolyte Physiol 271: F87-F93, 1996.
81. Ishige K, Chen Q, Sagara Y, and Schubert D. The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death. J Neurosci 21: 6069-6076, 2001.
82. Iversen BM, Amann K, Kvam FI, Wang X, and Ofstad J. Increased glomerular capillary pressure and size mediate glomerulosclerosis in SHR juxtamedullary cortex. Am J Physiol Renal Physiol 274: F365-F373, 1998.
83. Iversen BM and Arendshorst WJ. ANG II and vasopressin stimulate calcium entry in dispersed smooth muscle cells of preglomerular arterioles. Am J Physiol Renal Physiol 274: F498-F508, 1998.
84. Jeney V, Itoh S, Wendt M, Gradek Q, Ushio-Fukai M, Harrison D, and Fukai T. Role of antioxidant-1 in extracellular superoxide dismutase function and expression. Circ Res 96: 723-729, 2005.
85. Johnson RJ, Rodriguez-Iturbe B, Kang DH, Feig DI, and Herrera-Acosta J. A unifying pathway for essential hypertension. Am J Hypertens 18: 431-440, 2005.
86. Jones SA, O'Donnell VB, Wood JD, Broughton JP, Hughes EJ, and Jones OT. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol Heart Circ Physiol 271: H1626-H1634, 1996.
87. Jung O, Marklund SL, Geiger H, Pedrazzini T, Busse R, and Brandes RP. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res 93: 622-629, 2003.
88. Kawada N, Dennehy K, Solis G, Modlinger PS, Hamel R, Kawada JT, Aslam S, MOriyama T, Imai E, Welch WJ, and Wilcox CS. TP receptors regulate renal hemodynamics during ANG II slow pressor response. Am J Physiol Renal Physiol 287: F753-F759, 2004.
89. Kawada N, Imai E, Karber A, Welch WJ, and Wilcox CS. A mouse model of ANG II slow pressor response: role of oxidative stress. J Am Soc Nephrol 13: 2860-2868, 2002.
90. Khatri JJ, Johnson C, Magid R, Lessner SM, Laude KM, Dikalov SI, Harrison DG, Sung HJ, Rong Y, and Galis ZS. Vascular oxidant stress enhances progression and angiogenesis of experimental atberoma. Circulation 109: 520-525, 2004.
91. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, Welch WJ, and Wilcox CS. Salt intake, oxidative stress and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 14: 2775-2782, 2003.
92. Kitiyakara C and Wilcox CS. Antioxidants for hypertension. Nephrol Hypertens 7: 531-538, 1998.
93. Kojda G and Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes, and heart failure. Cardiovasc Res 43: 562-571, 1999.
94. Koo JR and Várnai P. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int 63: 195-201, 2002.
95. Kriz W. A periarterial pathway for intrarenal distribution of renin. Kidney Int 31: 51-56, 1987.
96. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schonbein GW, and Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension 36: 878-884, 2000.
97. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H, Holland SM, and Harrison DG. Role of p47(phox) in vascular oxidative stress and hypertension caused by ANG II. Hypertension 40: 511-515, 2002.
98. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endotheliai cells nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209, 2003.
99. phox homologues in vascular smooth muscle cells nox1 mediates ANG II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894, 2001.
100. Lassègue B and Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297, 2003.
101. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, and Harrison DG. Role of superoxide in ANG II-induced but not catecholamine-induced hypertension. Circulation 95: 588-593, 1997.
102. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, and Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for intersctions between peroxynitrite and tetrahydrobiopterin. Circulation 103: 1282-1288, 2001.
103. Laycock SK, Vogel T, Forfia PR, Tuzman J, Xu X, Ochoa M, Thompson CI, Nasjletti A, and Hintze TH. Role of nitric oxide in the control of renal oxygen consumption and the regulation of chemical work in the kidney. Circ Res 82: 1263-1271, 1998.
104. Lever AF. The fast and slow developing pressor effect of ANG II. In: The Renin-Angiotensin System, edited by Robertson JIS and Nicholls MG. London, UK: Gower Medical Publishing, 1993, p. 28.1-28.9.
105. Lever AF. Slow pressor mechanisms in hypertension: a role for hypertrophy or resistance vessels? J Hypertens 4: 515-524, 1986.
106. Levy MN and Imperial ES. Oxygen shunting in renal cortical and medullary capillaries. Am J Physiol 200: 159-162, 1961.
107. Li JM and Shah AM. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277: 19952-19960, 2002.
108. 2 and intracellular myoglobin. Am J Physiol Heart Circ Physiol 286: H47-H54, 2004.
109. 2-mediated mechanism of vascular contraction in hypertensive rats: relation to lipoxygenase and prostacyclin synthase activities. Circ Res 74: 197-205, 1994.
110. 1 receptors. Hypertension 43: 649-653, 2004.
111. 2 generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res 93: 573-580, 2003.
112. Lombardi D, Gordon KL, Polinsky P, Suga S, Schwartz SM, and Johnson RJ. Salt-sensitive hypertension develops after short-term exposure to ANG II. Hypertension 33: 1013-1019, 1999.
113. Long DA, Price KL, Herrera-Acosta J, and Johnson RJ. How does ANG II cause renal injury? Hypertension 43: 722-723, 2004.
114. Lotharius J and O'Malley KL. The Parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity. J Biol Chem 275: 38581-38588, 2000.
115. Luft FC, Wilcox CS, Unger T, Kuhn R, Demmert G, Rohmeiss P, Ganten D, and Sterzel RB. Angiotensin-induced hypertension in the rat: sympathetic nerve activity and prostaglandins. Hypertension 14: 396-403, 1989.
116. Luo Y and Roth GS. The roles of dopamine oxidative stress and dopamine receptor signaling in aging and age-related neurodegeneration. Antioxid Redox Signal 2: 449-460, 2000.
117. Majid DS and Nishiyama A. Nitric oxide blockade enhances renal responses to superoxide dismutase inhibition in dogs. Hypertension 39: 293-297, 2002.
118. Majid DSA, Nishiyama A, Jackson KE, and Castillo A. Superoxide scavenging attenuates renal responses to ANG II during nitric oxide synthesis inhibition in anesthetized dogs. Am J Physiol Renal Physiol 288: F412-F419, 2005.
119. 2 leads to hypertension. Hypertension 42: 25-30, 2003.
120. Makino A, Skelton MM, Zou AP, Roman RJ, and Cowley AW Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension 39: 667-672, 2002.
121. Manning RD Jr, Meng S, and Tian N. Renal and vascular oxidative stress and salt sensitivity of arterial pressure. Acta Physiol Scand 179: 243-250, 2003.
122. Mattson DL and Higgins DJ. Influence of dietary sodium intake on renal medullary nitric oxide synthase. Hypertension 27: 688-692, 1996.
123. Meng S, Cason GW, Gannon AW, Racusen LC, and Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41: 1346-1352, 2003.
124. Meng S, Roberts LJ, Cason GW, Curry TS, and Manning RD. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 283: R732-R738, 2002.
125. Modlinger P, Wilcox CS, and Aslam S. Nitric oxide, oxidative stress and progression of chronic renal failure. Semin Nephrot 24: 354-365, 2004.
126. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, and Munzel T. Effects of ANG II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90: E58-E65, 2002.
127. Moore LC, Yarimizu S, Schubert G, Weber PC, and Schnermann J. Dynamics of tubuloglomerular feedback adaptation to acute and chronic changes in body fluid volume. Pflügers Arch 387: 39-45, 1980.
128. Mori T and Cowley AW Jr. ANG II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 42: 588-593, 2003.
129. Moritz AR and Oldt MR. Arteriolar sclerosis in hypertensive and non-hypertensive individuals. Am J Pathol 13: 679-728, 1937.
130. Morrow JD and Roberts LJ. The isoprostanes: unique bioactive products of lipid peroxidation. Prog Lipid Res 36: 1-21, 1997.
131. 2-isoprostanes in vitro and in vivo-effects of oxygen tension and glutathione. Arch Biochem Biophys 353: 160-171, 1998.
132. Mundel P, Bachmann S, Bader M, Fischer A, Kummer W, Mayer B, and Kriz W. Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int 42: 1017-1019, 1992.
133. Muralikrishnan D and Ebadi M. SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. Brain Res 892: 241-247, 2001.
134. Nakamura T, Lozano PR, Ikeda Y, Iwanaga Y, Hinek A, Minamisawa S, Cheng CF, Kobuke K, Dalton N, Takada Y, Tashiro K, RossJ Jr, Honjo T, and Chien KR. Fibulin-5/DANCE is essential for elastogenesis. Nature 415: 171-175, 2002.
135. Nègre-Salvayre A, Hirtz C, Carrera G, Cazenave R, Troly M, Salvayre R, Pénicaud L, and Casteilla L. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J 11: 809-815, 1997.
136. Nguyen AD, Itoh S, Jeney V, Yanagisawa H, Fujimoto M, Ushio-Fukai M, and Fukai T. Fibulin-5 is a novel binding protein for extracellular superoxide dismutase. Circ Res 95: 1067-1074, 2004.
137. Ni Z, Hou S, Barton CH, and Vaziri ND. Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells. Kidney Int 66: 2329-2336, 2004.
138. Noh JS and Gwag BJ. Attenuation of oxidative neuronal necrosis by a dopamine D1 agonist in mouse cortical cell cultures. Exp Neurol 146: 604-608, 1997.
139. Norman JT, Clark IM, and Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 58: 2351-2366, 2000.
140. Norrelund H, Christensen KL, Samani NJ, Kimber P, Mulvany MJ, and Korsgaard N. Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 24: 301-308, 1994.
141. Ofstad J and Iversen BM. Glomerular and tubular damage in normotensive and hypertensive rats. Am J Physiol Renal Physiol. 288: F665-F672, 2005.
142. Ohara Y, Peterson TE, Zheng B, Kuo JF, and Harrison DG. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb 14: 1007-1013, 1994.
143. Ollerstam A, Pittner J, Persson AEG, and Thorup C. Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase. J Clin Invest 99: 2212-2218, 1997.
144. Onozato ML, Tojo A, Goto A, Fujita T, and Wilcox CS. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI or ARB. Kidney Int 61: 186-194, 2002.
145. Ortiz MC, Manriquez MC, Romero JC, and Juncos LA. Antioxidants block ANG II-induced increases in blood pressure and endothelin. Hypertension 38: 655-659, 2001.
146. Ortiz MC, Sanabria E, Manriquez MC, Romero JC, and Juncos LA. Role of endothelin and isoprostanes in slow pressor responses to ANG II. Hypertension 37: 505-510, 2001.
147. Ortiz PA and Garvin JL. NO inhibits NaCl absorption by rat thick ascending limb through activation of cGMP-stimulated phosphodiesterase. Hypertension 37: 467-471, 2001.
148. 2 and NO in the thick ascending limb. Hypertension 39: 591-596, 2002.
149. Ortiz PA and Garvin JL. Superoxide stimulates NaCl absorption by the thick ascending limb. Am J Physiol Renal Physiol 283: F957-F962, 2002.
150. Ortiz PA and Garvin JL. Role of nitric oxice in the regulation of nephron transport. Am J Physiol Renal Physiol 282: F777-F784, 2002.
151. 3-transport by rat thick ascending limb. Kidney Int 58: 2069-2074, 2001.
152. Pallone TL and Mattson DL. Role of nitric oxide in regulation of the renal medulla in normal and hypertensive kidneys. Curr Opin Nephrol Hypertens 11: 93-98, 2002.
153. Panza JA, Quyyumi AA, Brush JE Jr, and Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27, 1990.
154. Park JB, Touyz RM, Chen X, and Schiffrin EL. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats. Am J Hypertens 15: 78-84, 2002.
155. Patel K, Chen Y, Dennehy K, Welch W, and Wilcox CS. Antihypertensive response to nitroxides depends on superoxide dismutase activity and lipophilicity (Abstract). J Am Soc Nephrol 14, 29A. 2003.
156. Patzak A, Mrowka R, Storch E, Hocher B, and Persson PB. Interaction of ANG II and nitric oxide in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 12: 1122-1127, 2001.
157. Persson PB. Nitric oxide in the kidney. Am J Physiol Regul Integr Comp Physiol 283: R1005-R1007, 2002,
158. Plato CF, Shesely EG, and Garvin JL. eNOS mediates L-arginine-induced inhibition of thick ascending limb chloride flux. Hypertension 35: 319-323, 2000.
159. Ploth DW, Schnermann J, Dahlheim H, Hermle M, and Schmidmeier E. Autoregulation and tubuloglomerular feedback in normotensive and hypertensive rats. Kidney Int 12: 253-267, 1977.
160. Pu Q, Neves F, Virdis A, Touyz RM, and Schiffrin EL. Effect of endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling. Hypertension 42: 49-55, 2003.
161. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. ANG II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
162. Ramachandran A, Levonen AL, Brookes PS, Ceaser E, Shiva S, Barone MC, and Darley-Usmar V. Mitochondria, nitric oxide, and cardiovascular dysfunction. Free Radic Biol Med 33: 1465-1474, 2002.
163. Ren Y, Carretero OA, and Garvin JL. Mechanism by which superoxide potentiates tubuloglomerular feedback. Hypertension 39: 624-628, 2002.
164. Ren Y, Garvin JL, Ito S, and Carretero OA. Role of neuronal nitric oxide synthase in the macula densa. Kidney Int 60: 1676-1683, 2001.
165. Rhinehart K and Pallone TL. Nitric oxide generation by isolated descending vasa recta. Am J Physiol Regul Integr Comp Physiol 281: R1878-R1886, 2001.
166. Roczniak A, Zimpelmann J, and Burns K. Effect of dietary salt on neuronal nitric oxide synthase in the inner medullary collecting duct. Am J Physiol Renal Physiol 275: F46-F54, 1998.
167. Rodríguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chávez M, Herrera-Acosta J, Johnson RJ, and Pons HA. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 282: F191-F201, 2002.
168. Rodriguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, and Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41: 341-346, 2003.
169. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2001.
170. Rosenberger C, Griethe W, Gruber G, Wiesener M, Frei U, Bachmann S, and Eckardt KU. Cellular responses to hypoxia after renal segmental infarction. Kidney Int 64: 874-886, 2003.
171. Rosenberger C, Mandriota S, Jürgensen JS, Wiesener MS, Hörstrup JH, Frei U, Ratcliffe PJ, Maxwell PH, Bachmann S, and Eckardt KU. Expression of hypoxia-inducible factor-1α and- 2α in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13: 1721-1732, 2002.
172. Rubanyi GM and Vanhoutte PM. Superoxide anion and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 250: H822-H827, 1986.
173. Sarkela TM, Berthiaume J, Elfering S, Gybina AA, and Giulivi C. The modulation of oxygen radical production by nitric oxide in mitochondria. J Biol Chem 276: 6945-6949, 2001.
174. Sato A, Sakuma I, and Gutterman DD. Mechanism of dilation to reactive oxygen species in human coronary arterioles. Am J Physiol Heart Circ Physiol 285: H2345-H2354, 2003.
175. 2α. Hypertension 33: 424-428, 1999.
176. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 282: R335-R342, 2002.
177. Schnackenberg CG, Welch WJ, and Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32: 59-64, 1998.
178. - and NO. Am J Physiol Renal Physiol 279: F302-F308, 2000.
179. Schnermann J. Juxtaglomerular cell complex in the regulation of renal salt excretion. Am J Physiol Regul Integr Comp Physiol 274: R263-R279, 1998.
180. Schnermann J and Briggs JP. Effects of angiotensin and other pressor agents on tubuloglomerular feedback responses. Kidney Int 38: S77-S80, 1990.
181. Schnermann J, Traynor T, Pohl H, Thomas DW, Coffman TM, and Briggs JP. Vasoconstrictor responses in thromboxane receptor knockout mice: tubuloglomerular feedback and ureteral obstruction. Acta Physiol Scand 168: 201-207, 2000.
182. 1A receptor-deficient mice. Am J Physiol Renal Physiol 273: F315-F320, 1997.
183. Schricker K, Potzl B, Hamann M, and Kurtz A. Coordinate changes of renin and brain-type nitric-oxide-synthase (b-NOS) mRNA levels in rat kidneys. Pflügers Arch 432: 394-400, 1996.
184. Schurek HJ, Jost U, Baumgärtl H, Bertram H, and Heckmann U. Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am J Physiol Renal Fluid Electrolyte Physiol 259: F910-F915, 1990.
185. Sedeek MH, Llinas MT, Drummond H, Fortepiani L, Abram SR, Alexander BT, Reckelhoff JF, and Granger JP. Role of reactive oxygen species in endothelin-induced hypertension. Hypertension 42: 806-810, 2003.
186. Shimizu S, Shiota K, Yamamoto S, Miyasaka Y, Ishii M, Watabe T, Nishida M, Mori Y, Yamamoto T, and Kiuchi Y. Hydrogen peroxide stimulates tetrahydrobiopterin synthesis through the induction of GTP-cyclohydrolase I and increases nitric oxide synthase activity in vascular endothelial cells. Free Radic Biol Med 34: 1343-1352, 2003.
187. Shokoji T, Fujisawa Y, Kimura S, Rahman M, Kiyomoto H, Matsubara K, Moriwaki K, Aki Y, Miyatake A, Kohno M, Abe Y, and Nishiyama A. Effects of local administrations of Ternpol and diethyldithio-carbamic on peripheral nerve activity. Hypertension 44: 236-243, 2004.
188. Sigmon DH and Beierwaltes WH. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension. Hypertension 31: 649-656, 1998.
189. Sigmon DH and Beierwaltes WH. Degree of renal artery stenosis alters nitric oxide regulation of renal hemodynamics. J Am Soc Nephrol 5: 1369-1377, 2000.
190. Singh I, Grams M, Wang WH, Yang T, Killen P, Smart A, Schnermann J, and Briggs J. Coordinate regulation of renal expression of nitric oxide synthase, renin, and angiotensinogen mRNA by dietary salt. Am J Physiol Renal Fluid Electrolyte Physiol 270: F1027-F1037, 1996.
191. Skov K, Hamet P, Nyengaard JR, and Mulvany MJ. Morphology of renal afferent arterioles and glomeruli, heart weight, and blood pressure in primates. Am J Hypertens 14: 331-337, 2001.
192. Somers MJ, Mavromatis K, Galis ZS, and Harrison DG. Vascular Superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101: 1722-1728, 2000.
193. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Soreescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor R, and Griendling KK. Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation 105: 1429-1435, 2002.
194. Spiekermann S, Landmesser U, Dikalov S, Bredt M, Gamez G, Tatge H, Reepschläger N, Hornig B, Drexler H, and Harrison DG. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease. Circulation 107: 1383-1389, 2003.
195. Stoos BA, Carretero OA, and Garvin JL. Endothelial-derived nitric oxide inhibits sodium transport by affecting apical membrane channels in cultured collecting duct cells. J Am Soc Nephrol 4: 1855-1860, 1994.
196. Stoos BA and Garvin JL. Actions of nitric oxide on renal epithelial transport. Clin Exp Pharmacol Physiol 24: 591-594, 1997.
197. Stowe N, Schnermann J, and Hermle M. Feedback regulation of nephron filtration rate during pharmacologic interference with the renin-angiotensin and adrenergic systems in rats. Kidney Int 15: 473-486, 1979.
198. Suh YA, Arnold R, Lassègue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, and Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401: 79-82, 1999.
199. Suzuki H, DeLano FA, Parks DA, Jamshidi N, Granger DN, Ishii H, Suematsu M, Zweifach BW, and Schmid-Schonbein GW. Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats. Proc Natl Acad Sci USA 95: 4754-4759, 1998.
200. Swei A, Lacy F, DeLano FA, and Schmid-Schonbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension 30: 1628-1633, 1997.
201. 2d in the rat. J Clin Invest 90: 136-141, 1990.
202. Thomas DW, Rocha PN, Nataraj C, Robinson LA, Spurney RF, Koller BH, and Coffman TM. Proinflammatory actions of thromboxane receptors to enhance cellular immune responses. J Immunol 171: 6389-6395, 2003.
203. Thomson S, Vallon V, and Blantz RC. Asymmetry of tubuloglomerular feedback effector mechanism with respect to ambient tubular flow. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1123-F1130, 1996.
204. Thomson SC, Bachmann S, Bostanjoglo M, Ecelbarger CA, Peterson OW, Schwartz D, Bao D, and Blantz RC. Temporal adjustment of the juxtaglomerular apparatus during sustained inhibition of proximal reabsorption. J Clin Invest 104: 1149-1158, 1999.
205. Thorup C, Kornfeld M, Goligorsky MS, and Moore LC. AT1 receptor inhibition blunts ANG II-stimulated nitric oxide release in renal arteries. J Am Soc Nephrol 10: S220-S224, 1999.
206. Thorup C, Kornfeld M, Winaver JM, Goligorsky MS, and Moore LC. Angiotensin-II stimulates nitric oxide release in isolated perfused renal resistance arteries. Pflügers Arch 435: 432-434, 1998.
207. Thorup C and Persson EG. Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am J Physiol Renal Physiol F606-F611, 1994.
208. 2 uptake in dogs during hypoxia and hydrochlorothiazide infusion. Proc Soc Exp Biol Med 106: 714-717, 1961.
209. Tian N, Gannon AW, Khalil RA, and Manning RD Jr. Mechanisms of salt-sensitive hypertension: role of renal medullary inducible nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 284: R372-R379, 2003.
210. Tojo A, Bredt DS, and Wilcox CS. Distribution of postsynaptic density proteins in rat kidney: relationship to neuronal nitric oxide synthase. Kidney Int 55: 1384-1394, 1999.
211. Tojo A, Kimoto M, and Wilcox CS. Renal expression of constitutive NOS and DDAH: separate effects of salt intake and angiotensin. Kidney Int 58: 2075-2083, 2000.
212. Tojo A, Madsen K, and Wilcox CS. Expression of immunoreactive nitric oxide synthase isoforms in rat kidney: effects of dietary salt and losartan. Jpn Heart J 36: 389-398, 1995.
213. Tojo A, Welch WJ, Bremer V, Kimoto M, Kimura K, Omata M, Ogawa T, Vallance P, and Wilcox CS. Colocalization of demethylating enzymes and NOS and functional effects of methylargi nines in rat kidney. Kidney Int 52: 1593-1601, 1997.
214. Touyz RM. Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev Cardiovasc Ther 1: 91-106, 2003.
215. Touyz RM. Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep 2: 98-105, 2000.
216. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44: 248-252, 2004.
217. phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by ANG II. Circ Res 90: 1205-1213, 2002.
218. Tracy RE. Renovasculopathies of hypertension and the rise of blood pressure with age in blacks and whites. Semin Nephrol 16: 126-133, 1996.
219. Tracy RE and Overll EO. Arterioles of perfusion-fixed hypertensive and aged kidneys. Arch Pathol 82: 526-534, 1966.
220. Ullrich V and Bachschmid M. Superoxide as a messenger of endothelial function. Biochem Biophys Res Commun 278: 1-8, 2000.
221. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, and Koller A. High pressure induces Superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation 108: 1253-1258, 2003.
222. Valentin F, Field M, and Tippins JR. The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells. J Biol Chem 219: 8316-8324, 2004.
223. Vallance P, Collier J, and Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium dependent dilatation in human veins in vivo. Cardiovasc Res 23: 1053-1057, 1989.
224. Vallon V, Traynor T, Barajas L, Huang YG, Briggs JP, and Schnermann J. Feedback control of glomerular vascular tone in neuronal nitric oxide synthase knockout mice. J Am Soc Nephrol 12: 1599-1606, 2001.
225. - and is diminished by a high-salt diet. Am J Physiol Renal Physiol 287: F224-F230, 2004.
226. Vaziri ND, Dicus M, Ho ND, Boroujerdi-Rad L, and Sindhu RK. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int 63: 179-185, 2003.
227. Vaziri ND and Ding Y. Effect of lead on nitric oxide synthase expression in coronary endothelial cells: role of Superoxide. Hypertension 37: 223-226, 2001.
228. Vaziri ND, Ding Y, and Ni Z. Compensatory up-regulation of nitric-oxide synthase isoforms in lead-induced hypertension: reversal by a Superoxide dismutase-mimetic drug (Abstract). J Pharmacol Exp Ther 298: 678-685, 2001.
229. Vaziri ND, Liang K, and Ding Y. Increased nitric oxide inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int 56: 1492-1498, 1999.
230. Vaziri ND, Lin CY, Farmand F, and Sindhu RK. Superoxide dismutase, catalase, glutathione peroxidase and NADPH oxidase in lead-induced hypertension. Kidney Int 63: 186-194, 2002.
231. Vaziri ND, Ni Z, Oveisi F, Liang K, and Pandian R. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 39: 135-141, 2002.
232. Vaziri ND, Wang XQ, Oveisi F, and Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36: 142-146, 2000.
233. Villa LM, Salas E, Darley-Usmar V, Radomski MW, and Moncada S. Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci USA 91: 12383-12387, 1994.
234. Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, and Schiffrin EL. Sprionolactone improves angiotensin induced vascular changes and oxidative stress. Hypertension 40: 504-510, 2003.
235. Wang D, Borrego-Conde L, Falck JR, Sharma KK, Wilcox CS, and Umans JG. Contributions of NO, EDHF, and EETs to endothelium-dependent relaxation in rabbit renal afferent arterioles. Kidney Int 63: 2187-2193, 2003.
236. Wang D, Chabrashvili T, and Wilcox CS. Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxldative stress, thromboxane-prostanoid receptors and endothelium. Circ Res 94: 1436-1442, 2004.
237. Wang D, Chen Y, Chabrashvili T, Aslam S, Borrego L, Umans J, and Wilcox CS. Role of oxidative stress in endothelial dysfunction and enhanced responses to ANG II of afferent arterioles from rabbits infused with ANG II. J Am Soc Nephrol 14: 2783-2789, 2003.
238. Wang D, Chen Y, Chabrashvili T, Aslam S, Borrego L, Umans J, and Wilcox CS. Role of oxidative stress in endothelial dysfunction and enhanced responses to ANG II of afferent arterioles from rabbits infused with ANG II. J Am Soc Nephrol 14: 2783-2789, 2003.
239. Wang D, Iversen J, Wilcox CS, and Strandgaard S. Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease. Kidney Int 64: 1381-1388, 2003.
240. Wang H and Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med 27: 612-616, 1999.
241. Wang MH, Guan H, Nguyen X, Zand BA, Nasjletti A, and Laniado-Schwartzman M. Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20- hydroxyeicosatetraenoic acid synthesis in rat kidneys. Am J Physiol Renal Physiol 276: F246-F253, 1999.
242. phox in vascular smooth muscle. Am J Physiol Heart Circ Physiol 288: H37-H42, 2005.
243. Weber DS, Taniyama Y, Rocic P, Seshiah PN, Dechert MA, Gerthoffer WT, and Griendling KK. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration. Circ Res 94: 1219-1226, 2004.
244. Welch WJ, Ahlstrom NG, and Wilcox CS. Mechanism of hypertension during prolonged infusion of thromboxane mimetic. Eur J Int Med 2: 277-280, 1992.
245. 2 and renal oxygen usage in the hypertensive rat kidney. Kidney Int 59: 230-237, 2001.
246. 1 receptors. Kidney Int 63: 202-208, 2003.
247. Welch WJ, Blau J, Xie H, Chabrashvili T, and Wilcox CS. Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am J Physiol Heart Circ Physiol 288: H22-H28, 2005.
248. 1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney. Hypertension 41: 692-696, 2003.
249. Welch WJ, Mendonca M, Blau J, Karber A, Dennehy K, Lao Y, José P, and Wilcox CS. Antihypertensive response to prolonged Tempol in the SHR. Kidney Int 68: 179-187, 2005.
250. Welch WJ, Solis G, Chabrashvili T, Aslam S, Chen Y, and Wilcox CS. The role of renal superoxide dismutase (SOD) on blood pressure regulation during prolonged low-dose ANG II infusion. Hypertension. In press.
251. Welch WJ, Tojo A, Lee JU, Kang DG, Schnackenberg CG, and Wilcox CS. Nitric oxide synthase in the JGA of the SHR: expression and role in tubuloglomerular feedback. Am J Phvsiol Renal Physiol 277: F130-F138, 1999.
252. Welch WJ, Tojo A, and Wilcox CS. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol Renal Physiol 278: F769-F776, 2000.
253. Welch WJ and Wilcox CS. Feedback responses during sequential inhibition of angiotensin and thromboxane. Am J Physiol Renal Fluid Electrolyte Physiol 258: F457-F466, 1990.
254. Welch WJ and Wilcox CS. What is brain nitric oxide synthase doing in the kidney? Curr Opin Nephrol Hypertens 11: 109-115, 2002.
255. 1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int 59: 1257-1263, 2001.
256. Wersinger C, Chen J, and Sidhu A. Bimodal induction of dopamine-mediated striatal neurotoxicity is mediated through both activation of D1 dopamine receptors and autoxidation. Mol Cell Neurosci 25: 124-137, 2004.
257. Wilcox CS. L-arginine-nitric oxide pathway. In: The Kidney: Physiology and Pathophysiology, edited by Seldin DW and Giebisch G. New York: Raven Press, 2000, p. 851-873.
258. Wilcox CS. Reactive oxygen species: role in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
259. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand 179: 217-223, 2003.
260. Wilcox CS and Gutterman DD. Focus on oxidative stress in the cardiovascular and renal system. Am J Physiol Heart Circ Physiol 288: H3-H6, 2005.
261. Wilcox CS and Welch WJ. Macula densa nitric oxide synthase: expression, regulation, and function. Kidney Int 54: S53-S57, 1998.
262. Wilcox CS and Welch WJ. Interaction between nitric oxide and oxygen radicals in regulation of tubuloglomerular feedback. Acta Physiol Scand 168: 119-124, 2000.
263. Wilcox CS and Welch WJ. Thromboxane synthase and TP receptor mRNA in rat kidney and brain: effects of salt intake and ANG II. Am J Physiol Renal Physiol 284: F525-F531, 2003.
264. Wilcox CS and Welch WJ. Oxidative stress: cause or consequence of hypertension? Exp Biol Med (Maywood) 226: 619-620, 2001.
265. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, and Schmidt HH. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 89: 11993-11997, 1992.
266. Wingler K, Wünsch S, Kreutz R, Rothermund L, Paul M, and Schmidt HHHW. Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med 31: 1456-1464, 2001.
267. Wolin MS, Gupte SA, and Oeckler RA. Superoxide in the vascular system. J Vasc Res 39: 191-207, 2002.
268. Xia XG, Schmidt N, Teismann P, Ferger B, and Schulz JB. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation. J Neurochem 79: 63-70, 2001.
269. Xu H, Fink GD, Chen A, Watts S, and Galligan JJ. Nitric oxide-independent effects of Tempol on sympathetic nerve activity and blood pressure in normotensive rats. Am J Physiol Heart Circ Physiol 281: H975-H980, 2001.
270. - in DOCA-salt rats. Hypertension 43: 329-334, 2004.
271. Xu H, Fink GD, and Galligan JJ. Nitric-oxide-independent effects of Tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol 283: H885-H892, 2002.
272. Yanagisawa H, Davis EC, Starcher BC, Ouchi T, Yanagisawa M, Richardson A, and Olson EN. Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415: 168-171, 2002.
273. 5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 288: H55-H61, 2005.
274. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Quinn MT, and Jose PA. D5 dopamine receptor regulation of reactive oxygen species production and blood pressure in mice (Abstract). FASEB J 19: A1137, 2005.
275. .- expression in renal medullary interstitial cells. Am J Physiol Renal Physiol 284: F1207-F1215, 2003.
276. Yasunari K, Kohno M, Kano H, Minami M, and Yoshikawa J. Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors. Circulation 101: 2302-2308, 2000.
277. 2 in ANG II-induced vascular hypertrophy. Hypertension 32: 488-495, 1998.
278. Zeng C, Yang Z, Wang Z, Jones J, Wang X, Altea J, Mangrum AJ, Hopfer U, Sibley DR, Eisner GM, Felder RA, and Jose PA. Interaction of ANG II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension 45: 804-810, 2005.
279. Zhang Z, Rhinehart K, Lee-Kwon W, Weinman E, and Pallone TL. ANG II signaling in vasa recta pericytes by PKC and reactive oxygen species. Am J Physiol Heart Circ Physiol 287: H773-H781, 2004.
280. Zhang Z, Rhinehart K, Solis G, Pittner J, Kwon W, Welch WJ, Wilcox CS, and Pallone TL. Chronic ANG II infusion increases NO generation by rat descending vasa recta. Am J Physiol Heart Circ Physiol 288: H29-H36, 2005.
281. Zhou XJ, Vaziri ND, Wang XQ, Silva FG, and Laszik Z. Nitric oxide synthase expression in hypertension induced by inhibition of glutathione synthase. J Pharmacol Exp Ther 300: 762-767, 2002.
282. Zhu Z and Arendshorst WJ. ANG II-receptor stimulation of cytosolic calcium concentration in cultured renal resistance arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 271: F1239-F1247, 1996.
283. Zou AP, Li N, and Cowley AW. Production and actions of superoxide in the renal medulla. Hypertension 37: 547-553, 2001.
284. Zou AP, Wu F, and Cowley AW Jr. Protective effect of ANG II-induced increase in nitric oxide in the renal medullary circulation. Hypertension 31: 271-276, 1997.
285. Zou MH, Shi C, and Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817-826, 2002.